117 related articles for article (PubMed ID: 10360564)
21. Inter partes reexamination: a potentially useful approach to challenging invalid biotechnology patents.
Derzko NM; Behringer JW
Nat Biotechnol; 2003 Jul; 21(7):823-5. PubMed ID: 12833101
[No Abstract] [Full Text] [Related]
22. Biotech patents: looking backward while moving forward.
Eisenberg RS
Nat Biotechnol; 2006 Mar; 24(3):317-9. PubMed ID: 16525404
[No Abstract] [Full Text] [Related]
23. Biotech patents. Genentech, UC settle suit for $200 million.
Barinaga M
Science; 1999 Nov; 286(5445):1655. PubMed ID: 10610555
[No Abstract] [Full Text] [Related]
24. US Supreme Court applies strict limits to patents.
Robertson D
Nat Biotechnol; 2002 Jul; 20(7):639. PubMed ID: 12089532
[No Abstract] [Full Text] [Related]
25. US Supreme Court decision could compromise biotech patents.
Robertson D
Nat Biotechnol; 2001 May; 19(5):394. PubMed ID: 11328981
[No Abstract] [Full Text] [Related]
26. Patent due diligence in biotechnology transactions.
Gogoris AC; Clarke PJ
Nat Biotechnol; 2001 Mar; 19(3):279-81. PubMed ID: 11231565
[No Abstract] [Full Text] [Related]
27. Patents on genes: clarifying the issues.
Crespi RS
Nat Biotechnol; 2000 Jun; 18(6):683-4. PubMed ID: 10835611
[No Abstract] [Full Text] [Related]
28. Defensive use of publications in an intellectual property strategy.
Barrett B
Nat Biotechnol; 2002 Feb; 20(2):191-3. PubMed ID: 11821867
[No Abstract] [Full Text] [Related]
29. New rules for gene patents.
Grisham J
Nat Biotechnol; 2000 Sep; 18(9):921. PubMed ID: 10973202
[No Abstract] [Full Text] [Related]
30. Patents. U.S. Supreme Court delves into what is and isn't patentable.
Marshall E
Science; 2009 Jun; 324(5933):1374. PubMed ID: 19520926
[No Abstract] [Full Text] [Related]
31. Scientific misconduct. Science retracts discredited paper; bitter patent dispute continues.
Normile D
Science; 2009 Apr; 324(5926):450-1. PubMed ID: 19390012
[No Abstract] [Full Text] [Related]
32. Metal bashing.
Nat Biotechnol; 2001 May; 19(5):391. PubMed ID: 11328978
[No Abstract] [Full Text] [Related]
33. Biotechnology. Lawsuit challenges legal basis for patenting human genes.
Marshall E
Science; 2009 May; 324(5930):1000-1. PubMed ID: 19460975
[No Abstract] [Full Text] [Related]
34. European Commission rethinks biotech patents.
Mitchell P
Nat Biotechnol; 2002 Dec; 20(12):1175-6. PubMed ID: 12454654
[No Abstract] [Full Text] [Related]
35. Shortened life spans of biotech pioneer patents in Japan: a lesson from the DNA chip.
Aida T; Konishi A; Hagiwara M; Hashimoto K
Nat Biotechnol; 2007 May; 25(5):533-5. PubMed ID: 17483834
[No Abstract] [Full Text] [Related]
36. China overhauls patent law.
Qiu J
Nat Biotechnol; 2009 Mar; 27(3):214. PubMed ID: 19270657
[No Abstract] [Full Text] [Related]
37. Ethical aspects of patenting human genotypes according to EC Biotechnology Directive.
Spranger TM
IIC Int Rev Ind Prop Copyr Law; 2000 Jun; 31(4):373-80. PubMed ID: 12956125
[No Abstract] [Full Text] [Related]
38. Research tool patents: tips for facing a "pay up now or litigate" ultimatum.
Gogoris A; Ancona P
Nat Biotechnol; 2001 Nov; 19(11):1075-7. PubMed ID: 11689855
[No Abstract] [Full Text] [Related]
39. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.
Teitelbaum R; Cohen M
Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990
[No Abstract] [Full Text] [Related]
40. Scientific community. University clears Chinese biophysicist of misconduct.
Xin H
Science; 2006 Apr; 312(5773):511. PubMed ID: 16645056
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
